Drug application
LEVETIRACETAM IN SODIUM CHLORIDE (LEVETIRACETAM)
Drugs@FDA ANDA 219562 · CAPLIN
Key facts
| Drug name | LEVETIRACETAM IN SODIUM CHLORIDE |
|---|---|
| Active ingredients | LEVETIRACETAM |
| Application type | ANDA |
| Application number | 219562 |
| Company | CAPLIN |
| Dosage forms | INJECTABLE, INTRAVENOUS |
| Strength | 500MG/100ML (5MG/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jan 16, 2025 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.